Avelas Bio Raises $20M to Push Cancer-Illuminating Biologic Agent
Xconomy
AUGUST 17, 2016
and San Diego’s Avalon Ventures. Inbio Ventures, a venture capital management company, represented Pharmstandard in the deal. Avalon Ventures founded Avelas, and has housed the startup with other Avalon biotech startups at its COI Pharmaceuticals R&D facility in San Diego. Carmine Stengone.
Let's personalize your content